Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chinese Multicenter Phase II Trial of Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase

NCT07555678 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07555678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07555678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chinese Multicenter Phase II Trial of Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Recruiting
Start date
April 1, 2024
Completion date
December 31, 2028
Enrollment
241 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal squamous cell cancer